ATE482290T1 - Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung - Google Patents

Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung

Info

Publication number
ATE482290T1
ATE482290T1 AT06744682T AT06744682T ATE482290T1 AT E482290 T1 ATE482290 T1 AT E482290T1 AT 06744682 T AT06744682 T AT 06744682T AT 06744682 T AT06744682 T AT 06744682T AT E482290 T1 ATE482290 T1 AT E482290T1
Authority
AT
Austria
Prior art keywords
disorder
autism
gene
diagnosis
prevention
Prior art date
Application number
AT06744682T
Other languages
English (en)
Inventor
Anne Philippi
Francis Rousseau
Elke Roschmann
Original Assignee
Integragen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integragen Sa filed Critical Integragen Sa
Application granted granted Critical
Publication of ATE482290T1 publication Critical patent/ATE482290T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT06744682T 2005-03-24 2006-03-23 Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung ATE482290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66469705P 2005-03-24 2005-03-24
PCT/IB2006/001219 WO2006100608A2 (en) 2005-03-24 2006-03-23 Human autism susceptibility gene encoding a transmembrane protein and uses thereof

Publications (1)

Publication Number Publication Date
ATE482290T1 true ATE482290T1 (de) 2010-10-15

Family

ID=37024209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06744682T ATE482290T1 (de) 2005-03-24 2006-03-23 Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung

Country Status (11)

Country Link
US (1) US20090215040A1 (de)
EP (1) EP1863937B1 (de)
JP (1) JP2008537486A (de)
AT (1) ATE482290T1 (de)
AU (1) AU2006225995B2 (de)
CA (1) CA2601311A1 (de)
DE (1) DE602006017045D1 (de)
DK (1) DK1863937T3 (de)
ES (1) ES2350851T3 (de)
IL (1) IL185868A0 (de)
WO (1) WO2006100608A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2297351A1 (de) * 2008-06-12 2011-03-23 Integragen Kombination von mit autismus assoziierten risikoallelen
CA2726080A1 (en) * 2008-06-12 2009-12-17 Integragen A method for autism prediction
WO2011067296A1 (en) 2009-12-01 2011-06-09 Integragen A combination of eight risk alleles associated with autism
WO2011138372A1 (en) 2010-05-04 2011-11-10 Integragen A new combination of eight risk alleles associated with autism

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
JP3866760B2 (ja) 1993-02-22 2007-01-10 ザ ロックフェラー ユニバーシティ 一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
DE19911130A1 (de) * 1999-03-12 2000-09-21 Hager Joerg Verfahren zur Identifikation chromosomaler Regionen und Gene
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)
AU2003273640A1 (en) * 2002-10-10 2004-05-04 K.U. Leuven Research And Development Autism gene
WO2006003523A2 (en) * 2004-07-01 2006-01-12 Integragen Human autism susceptibility gene encoding prkcb1 and uses thereof

Also Published As

Publication number Publication date
IL185868A0 (en) 2008-01-06
EP1863937B1 (de) 2010-09-22
ES2350851T3 (es) 2011-01-27
JP2008537486A (ja) 2008-09-18
WO2006100608A2 (en) 2006-09-28
DE602006017045D1 (de) 2010-11-04
US20090215040A1 (en) 2009-08-27
WO2006100608A3 (en) 2007-04-05
CA2601311A1 (en) 2006-09-28
AU2006225995A1 (en) 2006-09-28
EP1863937A2 (de) 2007-12-12
DK1863937T3 (da) 2010-12-13
AU2006225995B2 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
MY164376A (en) Phosphospecific antibodies recognizing tau
Kálmán et al. Human dermal fibroblasts in psychiatry research
WO2008151803A3 (en) New polymorphisms in abcb1 associated with a lack of clinical response to medicaments
Gau et al. Identification of two inherited copy number variants in a male with autism supports two‐hit and compound heterozygosity models of autism
Kashevarova et al. Array CGH analysis of a cohort of Russian patients with intellectual disability
WO2010011283A3 (en) Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
ATE431855T1 (de) Menschliches autismus-suszeptibilitätsgen und verwendungen davon
Ben‐Reuven et al. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD
ATE457985T1 (de) Substituierte pyrazinonderivate zur verwendung als arzneimittel
IL185868A0 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
Rikos et al. TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort
ATE424469T1 (de) Für prkcb1 kodierendes humanes autismus- suszeptibilitätsgen und dessen verwendung
WO2006003520A3 (en) Human autism predisposition gene encoding a transcription factor and uses thereof
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
WO2006090288A3 (en) Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
FI3541784T3 (fi) Uudet atsetidiinijohdannaiset, jotka ovat hyödyllisiä kortikaalisen katekoliamiini-neurotransmission modulaattoreina
WO2006003526A3 (en) Human autism susceptibility gene encoding otoa and uses thereof
ATE471322T1 (de) Substituierte pyrazinonderivate zur verwendung als arzneimittel
JP2017500306A5 (de)
ATE443160T1 (de) Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung
Youssof et al. Potential role of serotonin transporter gene (5-Htt) polymorphism in temporal lobe epilepsy susceptibility in egyptian patients.
Singh P85, P50 evoked potential sensory gating as an endophenotype for schizophrenia
PH12013501724A1 (en) Glycine transporter-inhibiting substances
Lee Genetic modifiers of Huntington's disease
Juh et al. P. 5. b. 003 Alpha7 nicotinic acetylcholine receptor and apolipoprotein E polymorphisms in Alzheimer's dementia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1863937

Country of ref document: EP